LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced breast cancer: drug combo aims to halt tumor growth
Disease control Not yet recruitingThis study tests whether adding entinostat to fulvestrant can help control advanced breast cancer in people whose cancer has returned or worsened after standard treatment. About 50 women with HR+/HER2- breast cancer will receive the combination. The main goal is to see how long t…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New hope for advanced breast cancer: YL202 faces off against standard treatments
Disease control Not yet recruitingThis phase 3 study tests a new drug, YL202, against standard treatments (like eribulin or capecitabine) in 376 people with advanced HR+/HER2- breast cancer that has not responded to at least one chemotherapy. The main goal is to see if YL202 can delay cancer growth or improve sur…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New scan could replace biopsies for breast cancer patients
Knowledge-focused Not yet recruitingThis study tests a new imaging method (antibody-based PET scan) to see if it can predict how well a targeted cancer drug (T-DXd) works in people with advanced breast cancer. The goal is to potentially replace tumor biopsies with a less invasive scan. About 30 participants already…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC